Tokman Alexander Y 4
4 · ENDRA Life Sciences Inc. · Filed Jan 8, 2021
Insider Transaction Report
Form 4
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2021-01-08$0.90/sh−10,000$9,000→ 32,857 total
Footnotes (1)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan in order to pay the tax liability associated with the vesting of restricted stock units which were granted to the Reporting Person on April 9, 2020.